BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28230289)

  • 1. Mice lacking BCAS1, a novel myelin-associated protein, display hypomyelination, schizophrenia-like abnormal behaviors, and upregulation of inflammatory genes in the brain.
    Ishimoto T; Ninomiya K; Inoue R; Koike M; Uchiyama Y; Mori H
    Glia; 2017 May; 65(5):727-739. PubMed ID: 28230289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions.
    Fard MK; van der Meer F; Sánchez P; Cantuti-Castelvetri L; Mandad S; Jäkel S; Fornasiero EF; Schmitt S; Ehrlich M; Starost L; Kuhlmann T; Sergiou C; Schultz V; Wrzos C; Brück W; Urlaub H; Dimou L; Stadelmann C; Simons M
    Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ulk4 deficiency leads to hypomyelination in mice.
    Liu M; Xu P; Guan Z; Qian X; Dockery P; Fitzgerald U; O'Brien T; Shen S
    Glia; 2018 Jan; 66(1):175-190. PubMed ID: 29034508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.
    Li Z; He Y; Fan S; Sun B
    Neurosci Bull; 2015 Oct; 31(5):617-25. PubMed ID: 26253956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter?
    Gaupp S; Arezzo J; Dutta DJ; John GR; Raine CS
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1138-50. PubMed ID: 22082665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia.
    Zhang R; He J; Zhu S; Zhang H; Wang H; Adilijiang A; Kong L; Wang J; Kong J; Tan Q; Li XM
    Brain Res; 2012 Aug; 1469():136-43. PubMed ID: 22750584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of BCAS1-positive immature oligodendrocytes after cerebral ischemic stroke and SVD.
    Jiang G; Ayaki T; Maki T; Yasuda K; Yoshii D; Kaji S; Takahashi R
    Neurosci Lett; 2023 Aug; 812():137405. PubMed ID: 37479175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease.
    Xiang Z; Valenza M; Cui L; Leoni V; Jeong HK; Brilli E; Zhang J; Peng Q; Duan W; Reeves SA; Cattaneo E; Krainc D
    J Neurosci; 2011 Jun; 31(26):9544-53. PubMed ID: 21715619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.
    Georgiou E; Sidiropoulou K; Richter J; Papaneophytou C; Sargiannidou I; Kagiava A; von Jonquieres G; Christodoulou C; Klugmann M; Kleopa KA
    Brain; 2017 Mar; 140(3):599-616. PubMed ID: 28100454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal myelinogenesis both in the white and gray matter of the attractin-deficient mv rat.
    Izawa T; Yamate J; Franklin RJ; Kuwamura M
    Brain Res; 2010 Feb; 1312():145-55. PubMed ID: 19931230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin degeneration and diminished myelin renewal contribute to age-related deficits in memory.
    Wang F; Ren SY; Chen JF; Liu K; Li RX; Li ZF; Hu B; Niu JQ; Xiao L; Chan JR; Mei F
    Nat Neurosci; 2020 Apr; 23(4):481-486. PubMed ID: 32042174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
    Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
    Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
    Massa PT; Wu C; Fecenko-Tacka K
    J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal iron accumulation is involved in the pathogenesis of the demyelinating dmy rat but not in the hypomyelinating mv rat.
    Izawa T; Yamate J; Franklin RJ; Kuwamura M
    Brain Res; 2010 Aug; 1349():105-14. PubMed ID: 20599839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Hypomyelination and Developmental Defects Are Caused in Mice Lacking Protein Arginine Methyltransferase 1 (PRMT1) in the Central Nervous System.
    Hashimoto M; Murata K; Ishida J; Kanou A; Kasuya Y; Fukamizu A
    J Biol Chem; 2016 Jan; 291(5):2237-45. PubMed ID: 26637354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
    Bernard F; Moreau-Fauvarque C; Heitz-Marchaland C; Zagar Y; Dumas L; Fouquet S; Lee X; Shao Z; Mi S; Chédotal A
    Glia; 2012 Oct; 60(10):1590-604. PubMed ID: 22777942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.
    Yu H; Wu M; Lu G; Cao T; Chen N; Zhang Y; Jiang Z; Fan H; Yao R
    Brain Res; 2018 Jan; 1678():75-84. PubMed ID: 29038005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.